JV with Leading Men's Health Group for Online Platform
Filed with ASX · · 2 pages · English
Earlier from LTR Pharma
- SPONTAN Final Study Results
- FY24 Results Announcement
- Appendix 4E and Annual Financial Report
- SPONTAN Prescribed to First Patient by Authorised Prescriber
- LTP Secures Global CoDevelopment Agreement with Aptar Pharma
Later from LTR Pharma
- Trading Halt
- LTR Pharma Announces Successful A$25 million Placement
- Early Launch of Online Mens Health Platform
- Agreement with Men's Health Pharmacy for SPONTAN access
- Response to ASX Query Letters
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma